Browsing Tag
Vaccines
19 posts
Pneumococcal vaccine strategy shifts toward scale and integration with Vaxcyte Inc.’s VAX-31 Phase 3 push
Vaxcyte Inc. advances VAX-31 into pivotal trials. Find out what this means for vaccine competition, regulation, and long-term market positioning.
January 26, 2026
Anixa Biosciences (NASDAQ: ANIX) moves forward as Phase 1 breast cancer vaccine data clear safety and immune hurdles
Anixa Biosciences’ breast cancer vaccine met Phase 1 safety and immune response targets. Find out how Keytruda combinations could transform care.
December 12, 2025
Everest Medicines commissions mRNA vaccine production plant in Jiashan
Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang…
January 2, 2023
Panacea Biotec gets $127.3m worth orders for Easyfive-TT from UNICEF, PAHO
Panacea Biotec, an Indian biotechnology company, has been awarded supply orders worth $127.3 million from United Nations Children’s…
October 12, 2022
Moderna to build mRNA vaccine manufacturing plant in Victoria
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA)…
December 14, 2021
Wockhardt, RDIF strike deal with for Sputnik V and Sputnik Light vaccines
The Russian Direct Investment Fund (RDIF), the Russian sovereign wealth fund, has entered into a partnership with Indian…
August 18, 2021
Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy
Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated…
July 4, 2021
Wipro, Transcell Oncologics to transform safety assessment of vaccines
Wipro has entered into a partnership with Transcell Oncologics with an objective to transform safety assessments of vaccines…
May 6, 2021
Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to…
July 30, 2020
Pfizer begins phase 3 clinical trials of 20vPnC, RSVpreF, and MenABCWY vaccine candidates
US pharma giant Pfizer has initiated four phase 3 clinical trials within its present pipeline of investigational vaccines.…
June 22, 2020